Literature DB >> 25755592

Pathogenesis of Portal Cavernoma Cholangiopathy: Is it Compression by Collaterals or Ischemic Injury to Bile Ducts During Portal Vein Thrombosis?

Pankaj Puri1.   

Abstract

The pathogenesis of portal cavernoma cholangiopathy (PCC) is important as it can impact the choice of treatment modalities. PCC consists of a reversible component, which resolves by decompression of collaterals as well as a fixed component, which persists despite the decompression of collaterals. The reversible component is due to compression by large collaterals located adjacent to the bile duct as well as possibly intracholedochal varices. The fixed component is likely to be due to ischemia at the time of portal vein thrombosis, local ischemia by compression as well as encasement by a solid tumor-like cavernoma comprising of fibrous hilar mass containing multiple tiny collateral veins rather than markedly enlarged portal collaterals. Although cholangiographic abnormalities in portal hypertension are common, the prevalence of symptomatic PCC is low. This is likely to be related to the cause of portal hypertension, the duration of portal hypertension and possibly the pattern of occlusion of the splenoportal axis. There may possibly be higher prevalence of symptomatic PCC in extension of the thrombosis to the splenomesentric veins.

Entities:  

Keywords:  EHPVO, extrahepatic portal vein occlusion; ERC, endoscopic retrograde cholangiography; HABR, hepatic arterial buffer response; ITBL, ischemic-type biliary lesions; MR, magnetic resonance; PCC, portal cavernoma cholangiopathy; PVT, portal vein thrombosis; extrahepatic portal venous obstruction; obstructive jaundice; portal biliopathy; portal cavernoma

Year:  2014        PMID: 25755592      PMCID: PMC4244823          DOI: 10.1016/j.jceh.2013.05.015

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  44 in total

1.  Portal cholangiopathy: radiological classification and natural history.

Authors:  Elba Llop; Carmen de Juan; Susana Seijo; Angeles García-Criado; Juan G Abraldes; Jaume Bosch; Juan Carlos García-Pagán
Journal:  Gut       Date:  2011-01-26       Impact factor: 23.059

Review 2.  Portal hypertensive biliopathy.

Authors:  Radha K Dhiman; Arunanshu Behera; Yogesh K Chawla; Jang B Dilawari; Sudha Suri
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

3.  Immediate increase in arterial blood flow in embolized hepatic segments after portal vein embolization: CT demonstration.

Authors:  M Nagino; Y Nimura; J Kamiya; M Kanai; N Hayakawa; H Yamamoto
Journal:  AJR Am J Roentgenol       Date:  1998-10       Impact factor: 3.959

Review 4.  Collateral pathways in portal hypertension.

Authors:  Malay Sharma; Chittapuram S Rameshbabu
Journal:  J Clin Exp Hepatol       Date:  2012-12-16

Review 5.  How can portal vein cavernous transformation cause chronic incomplete biliary obstruction?

Authors:  Ozgur Harmanci; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

6.  Effect of shunt surgery on spleen size, portal pressure and oesophageal varices in patients with non-cirrhotic portal hypertension.

Authors:  B C Sharma; R P Singh; Y K Chawla; K L Narasimhan; K L Rao; S K Mitra; J B Dilawari
Journal:  J Gastroenterol Hepatol       Date:  1997-08       Impact factor: 4.029

7.  The effect of decreased portal blood flow on the biliary system.

Authors:  Y Saji
Journal:  Jpn J Surg       Date:  1988-09

8.  Portal hypertensive biliopathy: a rare cause of childhood cholestasis.

Authors:  Wael El-Matary; Eve A Roberts; Peter Kim; Michael Temple; Ernest Cutz; Simon C Ling
Journal:  Eur J Pediatr       Date:  2008-02-13       Impact factor: 3.183

9.  Gallstone formation in dogs after selective occlusion of the portal vein branches.

Authors:  T Eto
Journal:  Jpn J Surg       Date:  1988-05

10.  The "pseudo-cholangiocarcinoma sign" in patients with cavernous transformation of the portal vein and its effect on the serum alkaline phosphatase and bilirubin levels.

Authors:  Y Bayraktar; F Balkanci; A Ozenc; S Arslan; T Koseoglu; A Ozdemir; B Uzunalimoglu; H Telatar; A Gurakar; D H Van Thiel
Journal:  Am J Gastroenterol       Date:  1995-11       Impact factor: 10.864

View more
  5 in total

1.  Spectrum of biliary abnormalities in portal cavernoma cholangiopathy (PCC) secondary to idiopathic extrahepatic portal vein obstruction (EHPVO)-a prospective magnetic resonance cholangiopancreaticography (MRCP) based study.

Authors:  Shumyla Jabeen; Irfan Robbani; Naseer A Choh; Obaid Ashraf; Feroze Shaheen; Tariq Gojwari; Sabeeha Gul
Journal:  Br J Radiol       Date:  2016-10-12       Impact factor: 3.039

Review 2.  Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver.

Authors:  Radha K Dhiman; Vivek A Saraswat; Dominique C Valla; Yogesh Chawla; Arunanshu Behera; Vibha Varma; Swastik Agarwal; Ajay Duseja; Pankaj Puri; Naveen Kalra; Chittapuram S Rameshbabu; Vikram Bhatia; Malay Sharma; Manoj Kumar; Subhash Gupta; Sunil Taneja; Leileshwar Kaman; Showkat A Zargar; Samiran Nundy; Shivaram P Singh; Subrat K Acharya; Jang B Dilawari
Journal:  J Clin Exp Hepatol       Date:  2014-02-25

Review 3.  Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis.

Authors:  Daniel R Ludwig; Mark A Anderson; Malak Itani; Kedar G Sharbidre; Neeraj Lalwani; Raj M Paspulati
Journal:  Abdom Radiol (NY)       Date:  2022-05-18

4.  Bile duct wall calcification: A rare entity in portal cavernoma cholangiopathy.

Authors:  P N B Nitesh; B Pottakkat
Journal:  J Postgrad Med       Date:  2020 Oct-Dec       Impact factor: 1.476

Review 5.  Portal biliopathy.

Authors:  Mohammad S Khuroo; Ajaz A Rather; Naira S Khuroo; Mehnaaz S Khuroo
Journal:  World J Gastroenterol       Date:  2016-09-21       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.